Skip to main content

Advertisement

ADVERTISEMENT

Press Release

EO2 Concepts Launches Crowdfunding Campaign on StartEngine

San Antonio, TX. - Nov. 11, 2022 - Today, EO2 CONCEPTS® announced the launch of their Regulation Crowdfunding raise. With the funding goal of $5 million, EO2® will broaden access of their advanced oxygen-enhanced technology to the medical community and develop new product solutions as they become a leading standard of care for advanced wound healing and skin support.

EO2 Concepts is an advanced wound healing technology company leveraging continuous diffusion of oxygen (CDO) therapy to commercialize innovative medical modalities. The company’s primary in-market product is the OxyGeni® System, a wearable device designed to heal wounds to complete closure while simultaneously supporting skin and soft tissue restoration, shortening recovery time, reducing pain and minimizing the formation of scar tissue in the process.

“We are excited to bring this opportunity to a broader range of investors.“ said President and CEO, Mark Q Niederauer, PhD. “As our CDO therapy continues to rapidly grow and become a standard of care, we’ve had many physicians, patients and researchers express their wish that they could invest and be a part of the EO2 adventure. Through crowdfunding with StartEngine, we can make this possible.”

To learn more details about EO2 or how to invest through StartEngine go to: https://www.startengine.com/eo2 

About EO2®

EO2 Concepts® is a privately held, advanced wound care technology company based in San Antonio, TX. As the developer and manufacturer of a disruptive, FDA cleared medical device, they provide CDO Therapy which continuously delivers oxygen to tissues. Their flagship OxyGeni® System continuously produces oxygen directly from air and delivers the pure, humidified oxygen to target tissues, such as those with a wound or compromised skin, using an oxygen diffusion dressing. The system is able to monitor conditions within the dressing to ensure efficacious delivery of oxygen. CDO Therapy has been shown to heal wounds to complete closure while simultaneously supporting skin and soft tissue restoration, shortening recovery time, reducing pain and minimizing the formation of scar tissue in the process.

Source: EO2 Concepts

Advertisement

Advertisement

Advertisement